|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0165 - 0.0439|
|52 Week Range||0.0051 - 0.5850|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
United Cannabis Corporation (OTCBB: CNAB) (the "Company" or "United Cannabis") announced today that The Independent Physicians Association of America has selected the Company's CBD products for endorsement to and by its membership.
Cannabinoid focused biotechnology company United Cannabis Corporation (OTC: CNAB) said Thursday it has obtained a Notice of Allowance from the United States Patent and Trademark Office for its new patent application that declares procedures of using and preparing cannabinoid formulations. Once the company pays the necessary fees to the USPTO, this application will evolve into an issued patent.
United Cannabis Corporation (OTCBB: CNAB) (the "Company" or "United Cannabis") announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office ("USPTO") for its application for a new patent that claims methods of using and preparing cannabinoid formulations. The allowed application will mature into an issued patent once the issue fee is paid to the USPTO.